M&T Bank Corp Increases Stock Position in GE HealthCare Technologies Inc. $GEHC

M&T Bank Corp lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3,759.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 961,862 shares of the company’s stock after purchasing an additional 936,937 shares during the period. M&T Bank Corp’s holdings in GE HealthCare Technologies were worth $78,892,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the business. Capital Research Global Investors raised its holdings in shares of GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after buying an additional 4,998,154 shares during the last quarter. Dodge & Cox raised its holdings in shares of GE HealthCare Technologies by 16.8% in the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after buying an additional 3,949,361 shares during the last quarter. Boston Partners purchased a new position in shares of GE HealthCare Technologies in the third quarter worth $287,627,000. Temasek Holdings Private Ltd purchased a new position in shares of GE HealthCare Technologies in the third quarter worth $99,922,000. Finally, Hotchkis & Wiley Capital Management LLC increased its stake in shares of GE HealthCare Technologies by 17.1% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after acquiring an additional 1,232,828 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $72.26 on Wednesday. The company’s 50-day moving average price is $75.21 and its 200-day moving average price is $77.92. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a market cap of $32.97 billion, a P/E ratio of 15.85, a P/E/G ratio of 1.63 and a beta of 1.17. GE HealthCare Technologies Inc. has a twelve month low of $60.75 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 5 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.07%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on GEHC shares. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Mizuho cut their price objective on shares of GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating on the stock in a research note on Monday, April 13th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. The Goldman Sachs Group cut their price objective on shares of GE HealthCare Technologies from $97.00 to $81.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. Finally, Piper Sandler cut their price objective on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating on the stock in a research note on Friday. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $89.77.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.